GlassScriptPhysician profile
Kallayanee Techapatikul
NPI 1780936310
$1,179.31
in general payments reported to CMS, 2019-2025
16 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.64 · 2022: $126 · 2023: $62.56 · 2024: $541 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $331.06 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $181.86 | 2022-2024 | Xarelto |
| Abbott Laboratories | $158.07 | 2025 | Epic |
| Amgen INC. | $146.79 | 2021-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.87 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.18 | 2023-2024 | Jardiance |
| Abiomed | $44.36 | 2024 | Impella |
| Lantheus Medical Imaging, INC. | $26.35 | 2022 | |
| Esperion Therapeutics, INC. | $24.21 | 2023 | Nexletol |
| Atricure, INC. | $22.13 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $21.52 | 2025 | Camzyos |
| Teleflex LLC | $19.19 | 2025 | Guideliner |
| Pfizer INC. | $19.09 | 2025 | |
| La Jolla Pharmaceutical Company | $17.94 | 2025 | Giapreza |
| Impulse Dynamics (USA) INC. | $17.39 | 2024 | Optimizer |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $14.30 | 2025 | Restoreflow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kallayanee Techapatikul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.